Jeff Bezos Backed Grail: Early Bet or Costly Call?
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Stock indices provide benchmarks and a lens into market trends. This overview explains their purpose and how investors leverage them.
16,698 articlesWhen a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Investors are eyeing a renewed push for a classic dividend king as a robust oncology portfolio and resilience in earn...
Two tech giants define growth storytelling in 2026: one leads cloud security, the other powers AI infrastructure. Thi...
Investors have long looked to deals to jumpstart Netflix's growth. Five paraphrased lines from Netflix's co-CEO revea...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
As travel rebounds, premium demand is reshaping cruise stock dashboards. This deep dive explains why norwegian cruise...
The Meta deal lights up new questions about AMD's growth path and dilution risk. This guide breaks down what the 6 gi...
Viking Holdings (VIK) 2025 reveals how the company navigated a mixed year. This analysis breaks down Q4 results, marg...
Ally Financial is off to a challenging start in 2026, with shares down as inflation and tariff risks bite auto lendin...
ExxonMobil hovers around $150 as traders weigh mixed earnings against a long dividend-growth streak. The stock has ju...
A simple, disciplined approach to retirement investing can beat a maze of funds. Learn about three low-cost Vanguard ...